Routine inducement grants for new hires — no material impact on stock. Monitor for any future insider selling patterns or changes in employee retention, but this filing alone does not warrant trading action.
Price Chart
Executive Summary
Recursion Pharmaceuticals granted inducement RSU awards covering ~2.99 million shares to 33 new employees under its 2024 Inducement Equity Incentive Plan, as a material inducement to their employment. The awards vest over four years with a one-year cliff. This is a routine equity grant for new hires and does not reflect any change in business operations or financial performance.
Key Facts
- Inducement RSU awards covering 2,991,840 shares granted to 33 new employees.
- Awards vest 1/4th on first quarterly vesting date after one-year anniversary, then 1/16th quarterly thereafter.
- Grants made under the 2024 Inducement Equity Incentive Plan per Nasdaq Listing Rule 5635(c)(4).
- No financial terms or performance metrics disclosed; standard new-hire equity compensation.
Financial Impact
~2.99 million shares granted, representing approximately 0.9% of outstanding shares (based on ~330M shares outstanding per market cap of $1.8B at ~$5.45/share). No cash consideration.
Risk Factors
- Potential dilution of ~0.9% over vesting schedule, but immaterial in near term.
- No performance conditions — awards are time-based, so retention risk if stock declines.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3303818 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 424B5 | $3.47 $3.58 | ▼ −3.32% | ▼ −3.23% | $3.80 (−9.67%) |
Oct 15, 2026 11d ago | 8-K | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.80 (+8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | 424B5 | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.80 (+8.65%) |
Oct 6, 2026 20d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $3.80 (−17.93%) |
Oct 6, 2026 20d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $3.80 (−17.93%) |
Sep 21, 2026 5w ago | 8-K | $3.97 $3.70 | ▼ −6.80% | ▼ −5.78% | $3.80 (−4.28%) |
Sep 10, 2026 6w ago | Insider Cluster | $3.20 $3.83 | ▲ +19.69% | ▲ +20.03% | $3.80 (+18.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers